» Articles » PMID: 9826028

Triptolide Induces Apoptotic Death of T Lymphocyte

Overview
Date 1998 Nov 24
PMID 9826028
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Extract of Tripterygium wilfordii Hook. f (TWHf) has immunosuppressive activity and has been used as anti-inflammatory agent in traditional Chinese medicine for centuries. Recent studies have demonstrated that triptolide is the major active component in the extract that inhibits antigen or mitogen-induced T cell proliferation. In attempting to investigate its effect on activation of T lymphocytes, we found triptolide induces apoptotic death of T cell hybridomas and peripheral T cells but not that of thymocytes. The triptolide-induced apoptosis is accompanied by increase of DEVD-cleavable caspases activity and degradation of caspase substrate poly (ADP-ribose) polymerase (PARP). A specific inhibitor of caspases, zVAD-FMK, prevents triptolide-induced PARP degradation and DNA fragmentation but not growth arrest. Furthermore, enforced expression of Bcl-2 inhibited triptolide-induced degradation of PARP and apoptosis. These results indicate that triptolide induces T cell apoptosis through activating caspases, and suggest the growth arrest and apoptotic effect of triptolide may contribute to the immunosuppressive activity of TWHf extract.

Citing Articles

Effectiveness and safety of tripterygium wilfordii poly-glycosides on glomerulonephritis: a systematic review and meta-analysis.

Yan X, Shi J, Zhang Y, Liu J, Lin X, Yu C Front Pharmacol. 2024; 15:1339153.

PMID: 38841368 PMC: 11150713. DOI: 10.3389/fphar.2024.1339153.


New Therapeutic Horizon of Graves' Hyperthyroidism: Treatment Regimens Based on Immunology and Ingredients From Traditional Chinese Medicine.

He Q, Dong H, Gong M, Guo Y, Xia Q, Gong J Front Pharmacol. 2022; 13:862831.

PMID: 35462920 PMC: 9020194. DOI: 10.3389/fphar.2022.862831.


Mechanism of action of for treatment of idiopathic membranous nephropathy based on network pharmacology.

Shi H, Hou Y, Su X, Qiao J, Wang Q, Guo X Ren Fail. 2022; 44(1):116-125.

PMID: 35172688 PMC: 8856020. DOI: 10.1080/0886022X.2021.2024850.


Efficacy and safety of tripterygium glycosides for active moderate to severe Graves' ophthalmopathy: a randomised, observer-masked, single-centre trial.

Ye X, Zhao H, Liu J, Lu B, Shao J, Wang J Eur J Endocrinol. 2021; 184(2):277-287.

PMID: 33539318 PMC: 7849376. DOI: 10.1530/EJE-20-0857.


Application and Mechanisms of Triptolide in the Treatment of Inflammatory Diseases-A Review.

Yuan K, Li X, Lu Q, Zhu Q, Jiang H, Wang T Front Pharmacol. 2019; 10:1469.

PMID: 31866868 PMC: 6908995. DOI: 10.3389/fphar.2019.01469.